These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor. Shin JU; Park JH; Cho BC; Lee JH Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507 [TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer. Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP J Dermatolog Treat; 2016; 27(2):148-52. PubMed ID: 26313697 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid]. Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641 [TBL] [Abstract][Full Text] [Related]
7. Malassezia folliculitis presented as acneiform eruption after cetuximab administration. Cholongitas E; Pipili C; Ioannidou D J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376 [TBL] [Abstract][Full Text] [Related]
9. [Acneiform eruptions induced by cetuximab]. Walon L; Gilbeau C; Lachapelle JM Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857 [TBL] [Abstract][Full Text] [Related]
10. Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption. Park JH; Choi Y; Kim HJ; Oh SJ; Lee DY; Lee JH; Lee JH Dermatology; 2021; 237(3):457-463. PubMed ID: 33302268 [TBL] [Abstract][Full Text] [Related]
11. [Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors]. Tjin-A-ton ML; van Montfrans C; Koldenhof JJ; Sigurdsson V; Voest EE; Witteveen PO Ned Tijdschr Geneeskd; 2007 Apr; 151(17):945-52. PubMed ID: 17520845 [TBL] [Abstract][Full Text] [Related]
12. Grover's disease induced by cetuximab. Tscharner GG; Bühler S; Borner M; Hunziker T Dermatology; 2006; 213(1):37-9. PubMed ID: 16778425 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial. Tsutsui K; Kikuchi K; Nozawa K; Takashima A; Tsuchiyama K; Namikawa K; Aiba S; Yamazaki N J Dermatol; 2021 Jul; 48(7):1077-1080. PubMed ID: 33682955 [TBL] [Abstract][Full Text] [Related]
14. Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib. Anforth R; Liu M; Nguyen B; Uribe P; Kefford R; Clements A; Long GV; Fernandez-Peñas P Australas J Dermatol; 2014 Nov; 55(4):250-4. PubMed ID: 24313958 [TBL] [Abstract][Full Text] [Related]
15. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Gencoglan G; Ceylan C Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540 [TBL] [Abstract][Full Text] [Related]
16. Acneiform eruption induced by Iressa (gefitinib) tablets used to treat non-small cell lung cancer. Warthan MM; Jumper CA; Smith JL J Drugs Dermatol; 2004; 3(5):569-70. PubMed ID: 15552613 [TBL] [Abstract][Full Text] [Related]
17. Cetuximab-induced acne. Molinari E; De Quatrebarbes J; André T; Aractingi S Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741 [TBL] [Abstract][Full Text] [Related]
18. Acneiform eruption induced by molecularly targeted agents in antineoplastic therapy: A review. Yuan C; Wang B J Cosmet Dermatol; 2023 Aug; 22(8):2150-2157. PubMed ID: 36924348 [TBL] [Abstract][Full Text] [Related]
19. A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition. Wollenberg A; Moosmann N; Klein E; Katzer K Exp Dermatol; 2008 Sep; 17(9):790-2. PubMed ID: 18503553 [TBL] [Abstract][Full Text] [Related]
20. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta-analysis. Gorji M; Joseph J; Pavlakis N; Smith SD Asia Pac J Clin Oncol; 2022 Dec; 18(6):526-539. PubMed ID: 35352492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]